Martina Vrankar

Ljubljana, Slovenia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Local control and survival after stereotactic body radiation therapy of early-stage lung cancer patients in Slovenia.

Local control and survival after stereotactic body radiation therapy of early-stage lung cancer patients in Slovenia.

Journal: Radiology and oncology

Published: April 04, 2023

Various clinical presentations of uveitis associated with durvalumab treatment.

Various clinical presentations of uveitis associated with durvalumab treatment.

Journal: Radiology and oncology

Published: November 24, 2021

Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy - single institute experience.

Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy - single institute experience.

Journal: Radiology and oncology

Published: August 19, 2021

Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy.

Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy.

Journal: Radiation oncology (London, England)

Published: September 16, 2020

Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe.

Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe.

Journal: Radiology and oncology

Published: June 09, 2020

[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.

[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.

Journal: Radiology and oncology

Published: April 30, 2020

Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.

Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.

Journal: Radiology and oncology

Published: March 09, 2020

Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients.

Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients.

Journal: Radiology and oncology

Published: August 01, 2019

Lung Cancer in Slovenia.

Lung Cancer in Slovenia.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 12, 2019

Predicting tumour response to anti-PD-1 immunotherapy with computational modelling.

Predicting tumour response to anti-PD-1 immunotherapy with computational modelling.

Journal: Physics in medicine and biology

Published: December 19, 2018

Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy.

Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy.

Journal: Radiology and oncology

Published: February 05, 2018

PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy.

PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy.

Journal: Neoplasma

Published: January 12, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026